Methods of treating depression and other related diseases
US-9340576-B2 · May 17, 2016 · US
Methods of treating depression and other related diseases
US9796755B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9796755-B2 |
| Application number | US-201514616220-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2015 |
| Priority date | Oct 5, 2009 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to methods for treating depression, anxiety, and other related diseases by administering a peptide NMDAR partial agonist.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating anxiety in a patient in need thereof, comprising administering to said patient a 1 mg/kg to about 10 mg/kg dose of a compound represented by: or pharmaceutically acceptable salts, homologs, or hydrates thereof. 2. The method of claim 1 , comprising administering the dose once every week or every two weeks to said patient. 3. The method of claim 1 , wherein administration of a single dose is effective for up to 4 days.
Assignees
Inventors
Classifications
Tetrapeptides · CPC title
- C07K5/1013Primary
the side chain containing O or S as heteroatoms, e.g. Cys, Ser · CPC title
Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia · CPC title
with the first amino acid being heterocyclic, e.g. His, Pro, Trp · CPC title
Antidepressants · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9796755B2 cover?
- The invention relates to methods for treating depression, anxiety, and other related diseases by administering a peptide NMDAR partial agonist.
- Who is the assignee on this patent?
- Univ Northwestern
- What technology area does this patent fall under?
- Primary CPC classification C07K5/1013. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).